baber/WOPTO huggingface dataset:
Patent DE-69511944-D1 (DE)
Inventor: STAINTON JOHN ERNEST
IPC: B60W10/10
Filed: 1995-06-01
Granted: 1999-10-14
Abstract: A system and method for decreasing the time required to complete a ratio change in an electronically enhanced powertrain system (10) is provided. The powertrain system (10) includes a number of devices for providing a retarding torque to engine rotation to increase the decay rate of the engine speed during an upshift. These devices include an engine brake (32) and an input shaft brake (38). A retarding torque is also provided by increasing engine accessory load by controlling various engine accessories such as a cooling fan (30), an air compressor, a hydraulic pump, an air conditioning compressor (34), and an alternator. <IMAGE>
Patent DE-69515552-D1 (DE)
Inventor: ZEEUWE LEON JOSEPH GERARD
IPC: B29B9/08
Filed: 1995-04-19
Granted: 2000-04-20
Abstract: A process for the recycling of waste powder comprises (a) extruding the feedstock, comprising waste powder and opt. other feedstock components, into a homogeneous extrudate; and (b) transforming the extrudate into a first grade powder coating compsn. Prior to the above process a layer of waste powder is heated, at least up to coalescence of the powder but below decomposition or crosslinking of any part of the compsn. Also claimed is the appts. used in the above process comprising means for forming waste powder layer, opt. for transporting it, for heating it, for recovering the material, for transforming it into granules, for transporting the granules and for producing first grade powder.
Patent DE-69526371-D1 (DE)
Inventor: MESEROL M
IPC: A61F13/02
Filed: 1995-07-28
Granted: 2002-05-16
Abstract: An apparatus for photodynamic therapy (PDT) includes a cover (22) shaped to engage skin tissue (12) and a fiber optic panel (31) housed within the cover (22). Hydrogel (26) is located within the cover (22) and is in intimate physical and optical contact with the fiber optic panel (31) for optically coupling light from the fiber optic panel (31) to the skin tissue (12). The hydrogel (26) engages the stratum corneum (14) and hydrates and softens the stratum corneum (14) to enhance its optical transmissiveness to facilitate the transmission of light therethrough and to enhance its chemical transmissiveness to facilitate the transmission therethrough of photopharmaceuticals (28, 54) for treatment of a dermal lesion 10.
Patent DE-69527771-D1 (DE)
Inventor: AKAZAWA AKIRA
IPC: F01P11/00
Filed: 1995-01-13
Granted: 2002-09-19
Abstract: The invention relates to an engine coolant changing apparatus for changing an engine coolant such as LLC (long-life coolant) in an engine coolant path containing a radiator (6). The apparatus comprises coolant storing means (18) possessing a pressure action port (16) and a liquid inlet and outlet (17), detaching means (19) to be attached or detached to or from a filler port (2) of the radiator (6), communicating means (20) for communicating between the liquid inlet and outlet (17) and the detaching means (19), and pressure action means (21) for applying a negative pressure to the pressure action port (16) for lowering the boiling point of the coolant to overheat the coolant at a low temperature with a running engine when discharging the coolant from an engine coolant system (1), and applying a positive pressure to the pressure action port (16) when feeding a fresh liquid. In this way, the coolant can be changed promptly in a short time, without requiring manipulation of the radiator drain cock or jack-up of the vehicle. <IMAGE>
Patent DE-69533643-D1 (DE)
Inventor: VANDEPOPULIERE M
IPC: A23B5/005
Filed: 1995-01-03
Granted: 2004-11-18
Abstract: The present invention relates to producing a safer shell egg through thermal treatment. The present invention provides methods of producing a shell egg wherein the albumen and the yolk of the shell egg receives a thermal treatment sufficient to pasteurize the shell egg and thereby combat the risk of salmonella. The present invention provides methods of providing thermal treatments to the shell egg through introduction of the shell egg into an aqueous solution of a predetermined temperature and maintaining the shell egg in the solution for a predetermined time sufficient to cause the required reduction in salmonella. The predetermined times and temperatures may be characterized by use of the equivalent point method of thermal evaluation, by use of the F<SUB>0 </SUB>line for shell egg or by other methods of determining the reduction in salmonella.
Patent DE-69534876-D1 (DE)
Inventor: MENA CAMPOS JESUS
IPC: A01N63/20
Filed: 1995-08-10
Granted: 2006-05-11
Abstract: A method for obtaining a bacterial strain having nematicidal properties comprises collecting samples of soil and/or plant tissues from an area affected by nematodes, distinguishing samples of highly affected material from samples of less affected material, isolating bacterial strains present in said samples, comparing bacterial strains present in highly affected samples with strains present in less affected samples, selecting strains present only in the less affected samples, testing nematicidal properties of the selected strains and selecting those bacterial strains having useful nematicidal properties. A method for the biocontrol of nematodes comprises contacting the soil, a plant or a seed with an effective quantity of a nematicidal agent which is a culture obtained from Sphingo bacterium spiritivorum C-926 and/or Corynobacterium pauro metabolum C-924, or a metabolite derived from the said strain, obtained by natural, recombinant or synthetic route, in an appropriate carrier, or using the said nematicidal agent in a veterinary compsn. for the control of 300 nematodes. The said cultures, used as nematodicidic agent in this method, or any mutation derived from them which is active against nematodes, are also claimed, as are nematicidic agents comprising the said agents and an appropriate carrier.
Patent DE-69603208-D1 (DE)
Inventor: CARRUEL ANDRE
IPC: B23K9/035
Filed: 1996-01-29
Granted: 1999-08-19
Abstract: In a process for gas-shielded electric butt welding of two metal sheets (14,15) by current passage between at least one of the sheets and an electrode moved progressively along the edges (16,17) to be welded, the novelty comprises (a) placing, on the sheets prior to current passage, a flexible metal strip with two border regions coated with a heat resistant contact adhesive (pref. of cross-linked acrylic type or silicone type) for bonding onto the back faces of the sheets such that the regions extend parallel to the sheet edges (16,17); and (b) sweeping the strip middle region, between the border regions, with gas. Pref. the sheets are of stainless steel and the strip is of aluminium. Also claimed is a device for carrying out the above process and comprising a flexible metal strip coated with heat resistant contact adhesive in two border regions on one side of the strip.
Patent DE-69606087-D1 (DE)
Inventor: GLEJBOL KRISTIAN
IPC: H05H1/46
Filed: 1996-05-02
Granted: 2000-02-17
Abstract: A method for excitation of a plasma, characte-rized in that it comprises the step of subjecting a gas to an electric field generated by an electrode system comprising n electrodes, n being an integer greater than or equal to 3, preferably between 3 and 30, each of the n electrodes being connected to one of the following AC voltages: <MATH>   <MATH>   <MATH>   <MATH>  where:   f is a frequency in the range of 10 to 10000 Hz, preferably 30 to 200 Hz, more preferably 50 to 60 Hz, U0 is a voltage in the range of 50 to 10000 V, at least one electrode being connected to Ur, at least one electrode being connected to Us and at least one electrode being connected to Ut. The invention also concerns an electrode system for carrying out the method and the use of the electrode system. <IMAGE>
Patent DE-69613725-D1 (DE)
Inventor: YANG YEONG-SHOW
IPC: B29C70/34
Filed: 1996-01-31
Granted: 2001-08-16
Abstract: A composite is produced by arranging several different materials, one of which is a material with oriented reinforcement, pre-impregnated with a resin and moulding at raised temp. for a time sufficient to harden the resin and ensure bonding between the components. The components, including the resin, are arranged at the same time, before raising the temp., i.e. the resin is not injected separately after the other components have been arranged. The resin is a modified polyester-polyurethane prepd. by reacting (1) a 1st component comprising (A) a polyisocyanate with functionality 2-3, and (B) a peroxide able to initiate free radical polymerisation, in proportion such that (B)/(A) + (B) is 0.5-4 wt.%, with (2) a 2nd component comprising (a) a polyester polyol obtd. from an ethylenically unsatd. diacid or anhydride and a polyhydric alcohol, in molar ratio of alcohol:acid of 1.3-2.0, (b) an ethylenically unsatd. monomer in proportion such that (b)/(a)+(b) is 10-50 wt.%, (c) 0-4%, w.r .t. the 2nd component, of a promoter of the decomposition of the peroxide initiator at 20 degrees C, (d) 0-4%, w.r.t. the 2nd component, of a catalyst for the isocyanate-alcohol reaction, and (e) a hydroxylated (alk)acrylate in proportion such that (e)/(a)+(e) is 0.1-35 wt.%. The molar ratio between the NCO functions in (1) : the sum of the OH functions in (2) is 0.7-1.1.
Patent DE-69619668-D1 (DE)
Inventor: KELM ROBERT
IPC: A61K9/30
Filed: 1996-05-16
Granted: 2002-04-11
Abstract: The present invention relates to a pharmaceutical composition in a unit dosage form for peroral administration in a human or lower animal, having a gastrointestinal tract comprising a small intestine and a colon with a lumen therethrough having an inlet to the colon from the small intestine, comprising: a. a safe and effective amount of a therapeutically active agent incorporated into or coated on the surface of a dosage form selected from the group consisting of a spherical substrate, an elliptical substrate, a hard capsule, or a compressed tablet, with a maximum diameter of about 3 mm to about 10 mm; and b. an enteric polymer coating material comprising at least one inner coating layer and one outer coating layer; wherein the dosage form has a smooth surface free from edges or sharp curves; the elliptical substrate and the hard capsule have a ratio of the long to short diameters of no greater than about 1.5; the therapeutically active agent is released at a point near the inlet to, or within the colon; each of the inner coating layer(s) is an enteric polymer that begins to dissolve in an aqueous media at a pH between about 5 to about 6.3; and the outer coating layer is an enteric polymer that begins to dissolve in an aqueous media at a pH between about 6.8 to about 7.2.
Patent DE-69621230-D1 (DE)
Inventor: VERMEIDEN PIETER
IPC: B01L3/00
Filed: 1996-02-13
Granted: 2002-06-20
Abstract: Counting compartment having an inlet and an outlet, and including a bottom plate and a top plate which are held at a distance from each other by material particles which have the same size and are situated at a distance from one another. The particles are surrounded by and embedded in a solid connecting layer formed by an adhesive. The connecting layer extends all around and up to the free end of the outlet of the counting compartment. A fluent mixture of an adhesive mixed with electrostatically charged particles is used to form the counting compartment, the largest size of the material particles determining the depth of the counting compartment. The counting compartment is particularly suitable for counting cells in biological materials such as sperm and blood samples.
Patent DE-69632199-D1 (DE)
Inventor: MORIYA TAKEO
IPC: C12N15/52
Filed: 1996-09-11
Granted: 2004-05-19
Abstract: PCT No. PCT/JP96/02585 Sec. 371 Date Jan. 8, 1997 Sec. 102(e) Date Jan. 8, 1997 PCT Filed Sep. 11, 1996 PCT Pub. No. WO97/10340 PCT Pub. Date Mar. 20, 1997There is disclosed a process for producing D-pantoic acid or D-pantothenic acid utilizing the capability of the microorganism to synthesize D-pantoic acid or D-pantothenic acid. According to this process, (a) D-pantoic acid is biosynthesized from various carbon sources such as glucose to accumulate it in the culture medium, or (b)  beta -alanine is contacted with the microorganism by, for example, adding  beta -alanine to the culture medium, to cause condensation of the biosynthesized D-pantoic acid with  beta -alanine to accumulate D-pantothenic acid in the medium.
Patent DE-69633502-D1 (DE)
Inventor: NAKAHARA KOICHI
IPC: A23K1/16
Filed: 1996-12-26
Granted: 2004-11-04
Abstract: An antiobestic agent which has, in addition to the antiobestic effect, the effects of inhibiting saccharolytic digestive enzymes, suppressing an increase in blood sugar level, inhibiting the absorption of monosaccharides, adsorbing and excreting cholic acid, lowering cholesterol level and blood triglyceride level and, inhibiting lipase and is useful not only as an antiobestic agent but also as antilipotrophic, antihyperlipidemic, antiarteriosclerotic and antidiabetic agents. An extract of tamarind seed coat being rich un procyanidin (trimer of formula (I)), which is the active ingredient in the antiobestic agent, exerts as such a potent antiobestic effect without being purified any more. The antiobestic agent serves as a saccharolytic digestive enzyme inhibitor, a hypoglycemic agent, a monosaccharide absorption inhibitor, a cholic acid adsorption/excretion agent, a cholesterol-lowering agent, a blood triglyceride level-lowering agent and a lipase inhibitor and facilitates the production of foods, drinks and feeds showing these effects, thus contributing to the amelioration or prevention of diabetics or obesity in daily life.
Patent DE-69634853-D1 (DE)
Inventor: QUAX JOHANNES
IPC: C07K14/32
Filed: 1996-07-05
Granted: 2005-07-21
Abstract: Heterologous protein secretion from Gram-positive bacteria, in particular from Bacilli has, with few exceptions, met with little success. Incompatibility of the heterologous proteins with the protein secretion machinery of the host is the main cause of this effect. This limiting factor for the production of heterologous proteins in commercially significant concentrations from Bacillus subtilis is removed by overexpressing the Bacillus subtilis protein FtsY or FtsY protein in combination with overexpression of other members of the bacterial signal recognition particle. Said gene(s) is(are) overexpressed in Bacillus host cells expressing a heterologous protein which then shows an increased amount of the heterologous protein secreted in the surrounding medium.
Patent DE-69637593-D1 (DE)
Inventor: ZALEWSKI ANDREW
IPC: A61K48/00
Filed: 1996-04-19
Granted: 2008-08-21
Abstract: A method and compounds are provided for inhibiting the synthesis of extracellular matrix proteins. Compounds of the invention comprise oligonucleotides specific for nuclear proto-oncogenes. Preferably, oligonucleotides of the invention are selected from the group consisting of c-myc and c-myb and are locally administered. The invention finds use in the treatment of a variety of disorders, including sclerotic disorders and restenosis, associated with the inappropriate synthesis of extracellular matrix proteins, particularly collagen.
Patent DE-69700190-D1 (DE)
Inventor: DODSON ROBERT W
IPC: A01K1/015
Filed: 1997-01-24
Granted: 1999-05-27
Abstract: A cattle mattress (10) made from a woven fabric which is double-woven in areas (12) across the fabric into which crumb rubber (14) is inserted and which are closed off after insertion of the crumb (14) rubber to make a self-contained structure for the comfort of animals.   <IMAGE>
Patent DE-69702135-D1 (DE)
Inventor: DEVAUX FRANCOIS
IPC: G06F1/00
Filed: 1997-07-22
Granted: 2000-06-29
Abstract: A system for securely storing CD-ROM data including a CD-ROM having data encrypted at least in part with a cryptographic algorithm having a decryption key K, a CD-ROM drive for receiving the CD-ROM, an electronic decryption microcircuit embedded in the CD-ROM, means for exchanging information between the CD-ROM drive and the electronic decryption microcircuit embedded in the CD-ROM, and a chip card containing at least a part K1 of the decryption key K, any remaining part K2 of the decryption key K being in the electronic decryption microcircuit embedded in the CD-ROM. Also included is a secure means for securely exchanging information between the chip card and the electronic microcircuit embedded in the CD-ROM. Further, the electronic decryption microcircuit embedded in the CD-ROM includes an antenna which provides, without the presence of contact, both an electrical power supply to the decryption microcircuit from an external source and exchanges of information with the external source.
Patent DE-69711460-D1 (DE)
Inventor: APPLETON ROBERT PATRICK
IPC: B60C27/00
Filed: 1997-08-19
Granted: 2002-05-02
Abstract: A traction device, preferably formed of an elastomer material, has molded threads and is designed to encapsulate a tire of a vehicle. The traction device has a body with a pair of distal ends. At one of the ends a pair of metal hooks are pivotally mounted to a hinge pin. When the traction device is placed around the tire, the metal hooks engage a locking pin disposed on the other end of the body. A bladder is mounted to an inner surface of the body such that the bladder becomes sandwiched between the body and the tire. Tension and grip is applied to the traction device by inflating the bladder. Air is introduced via an air valve through a communication duct. Once mounted, the traction device essentially becomes an integral member of the vehicle tire, thereby enhancing the traction of the drive wheels.
Patent DE-69713099-D1 (DE)
Inventor: HEIKKILAE HEIKKI
IPC: C07B61/00
Filed: 1997-06-23
Granted: 2002-07-11
Abstract: The invention relates to a method for producing xylitol from a material containing xylose and xylonic acid. According to the method, xylose and xylonic acid are separated from the material containing xylose and xylonic acid, whereafter the separated xylose and xylonic acid are reduced to xylitol, and the xylitol is recovered.
Patent DE-69729387-D1 (DE)
Inventor: SHERMAN C
IPC: A61B19/00
Filed: 1997-09-24
Granted: 2004-07-08
Abstract: A multi-axial bone screw assembly includes a bone screw having a partially spherical head. The bone screw head is truncated at an upper surface in which a tool receiving recess is defined. The assembly includes a receiver member including a central bore that defines a tapered recess to receive a contracting collet carrying the head of the bone screw. The bore of the receiver member also defines a channel communicating with the recess and configured to receive a spinal rod therein. A portion of the channel is threaded to receive a set screw above the rod. The assembly also includes a contracting collet disposed between the rod and the head of the bone screw. The collet defines a partially spherical recess to receive the head of the bone screw, and includes deflectable fingers that substantially surround the screw head. As the set screw is tightened into the receiver member, the set screw compresses the rod against the collet, which presses the collet into the tapered recess of the receiver member, thereby deflecting the fingers of the collet against the bone screw head.
Patent DE-69734157-D1 (DE)
Title: Parathyroidhormon-verwandthe peptidanaloge
Inventor: GARDELLA THOMAS J
IPC: C07K14/635
Filed: 1997-07-30
Granted: 2005-10-13
Abstract: The present invention relates to novel PTHrP analogs that have been converted into potent PTH-2 receptor agonists or antagonists by the substitution of one or more amino acid residues of PTHrP to the corresponding residue(s) of PTH. A method of treating various disease states associated with altered function of the PTH-2 receptor, using these PTHrP analogs, is also described.
Patent DE-69735040-D1 (DE)
Inventor: NISHIGAKI JUNJI
IPC: C09B23/01
Filed: 1997-07-17
Granted: 2006-03-30
Abstract: An oxonol compound is represented by the following formula (I): <CHEM> in which each of Z, W<1> and W<2> independently is an atomic group that forms a heterocyclic ring; and M is a cation. A process for the synthesis of an oxonol compound is disclosed.
Patent DE-69738139-D1 (DE)
Inventor: GRIMSRUD KNUT
IPC: G06F3/06
Filed: 1997-07-11
Granted: 2007-10-25
Abstract: An apparatus is programmed with a plurality of programming instructions for generating, if possible, an alternative disk block allocation for a current disk block allocation that will yield improved overall access time for a sequence of disk accesses. In some embodiments, the programming instructions include the logic for tracing the sequence of disk accesses to determine the current disk block allocation, the logic for generating the alternative disk block allocation, if possible, using the trace results, and the logic for effectuating the alternate disk block allocation, if generated. In one particular embodiment, the logic for generating the alternative disk block allocation employs a random search approach, while in another embodiment, the logic for generating the alternative disk block allocation employs a heuristic approach.
Patent DE-69738265-D1 (DE)
Inventor: ROSAEN LARS OSCAR
IPC: G01F1/66
Filed: 1997-06-05
Granted: 2007-12-20
Abstract: An improved ultrasonic vortex fluid flowmeter (10) includes a housing (12) having a slip-on yoke (16) which removably mates with a bluff body conduit connector (18) permanently installed in a fluid conduit to be monitored. An ultrasonic transmitter (40) and receiver (42) are respectively positioned within the legs of the yoke so as pass an ultrasonic wave through vortices (43) shed by the fluid as it flows by the bluff body (28). The slip-on yoke eliminates both the need to shut down fluid flow during meter servicing, and the potential for external contaminants entering the fluid. The flowmeter further utilizes a simple phase detector formed from an Exclusive Or gate (44) in combination with an optimal phase range detecting means (108). The optimal phase range detecting means triggers a 90 degree phase shift whenever the phase difference between the transmitted wave and the received wave approaches 0 or 180 degrees. <IMAGE>
Patent DE-69739183-D1 (DE)
Inventor: RALSTON STUART
IPC: C12Q1/6883
Filed: 1997-02-28
Granted: 2009-02-12
Abstract: Diagnostic means that determines the genotype of a collagen gene of an individual is described. A polymorphism in the collagen gene correlates with predisposition to osteoporosis, so diagnosis of a predisposition is achieved using the diagnostic means. An isolated gene comprising the nucleotide substitution of the polymorphism is also described, as is a method of diagnosis based on the presence or absence of the polymorphism.
Patent DE-69800571-D1 (DE)
Inventor: KONDOH SHUNICHI
IPC: G11B15/087
Filed: 1998-11-24
Granted: 2001-04-12
Abstract: Comparators (CP1-CP10) receiving reference voltages (Vref1-Vref10) are provided. An output signal (APout) from a differential amplifier (4) is applied to these comparators (CP1-CP10). Here, the relationship of Vref1>Vref2>Vref3>Vref4>Vref5>Vbias>Vref6>Vref7>Vref8>Vref9>Vref10 is established. The output signals (CPout1-CPout10) from the comparators (CP1-CP10) are applied to a data latch/threshold level select circuit (101). The select circuit (101) retains the maximum peak level of the prior comparison by the comparators (CP1-CP5), and retains the minimum peak value of the prior comparison by the comparators (CP6-CP10). The select circuit (101) selects the output signal of the comparator of one lower level than the comparator that detects the maximum peak level at the prior comparison to supply the selected signal to a RS flip-flop circuit (13), and selects the output signal of the comparator of one higher level than the comparator that detects the minimum peak level at the prior comparison to supply the selected signal to the RS flip-flop circuit (13). The RS flip-flop circuit (13) outputs a detection signal (Dout) of a VISS signal in response to these select signals (SCPouth, SCPout1). As a result, a VISS signal detection circuit can reliably detect only the VISS signal without detecting the erase noise. <IMAGE>